9.87

0.61% -0.04

Optimizerx Corp (OPRX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$9.91

Offen:

$9.91

24-Stunden-Volumen:

17,229

Relative Volume:

0.03

Marktkapitalisierung:

$178.28M

Einnahmen:

$62.81M

Nettoeinkommen (Verlust:

$-13.75M

KGV:

-12.34

EPS:

-0.8

Netto-Cashflow:

$153.00K

1W Leistung:

-1.99%

1M Leistung:

+18.82%

6M Leistung:

+56.85%

1J Leistung:

-9.72%

1-Tages-Spanne:

$9.877

$10.19

1-Wochen-Bereich:

$9.115

$10.40

52-Wochen-Spanne:

$3.78

$14.13

Optimizerx Corp Stock (OPRX) Company Profile

Firmenname

Optimizerx Corp

Sektor

Healthcare (1153)

Branche

Health Information Services (53)

Telefon

248-651-6558

Adresse

260 CHARLES STREET, WALTHAM, MI

Mitarbeiter

129

Twitter

@OpRxTweets

Nächster Verdiensttermin

2025-03-12

Neueste SEC-Einreichungen

OPRX's Discussions on Twitter

Vergleichen Sie OPRX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
OPRX Optimizerx Corp	9.89	178.28M	62.81M	-13.75M	153.00K	-0.80
VEEV Veeva Systems Inc	237.69	37.82B	2.75B	714.14M	1.09B	4.33
DOCS Doximity Inc	59.44	10.90B	516.85M	174.11M	217.38M	0.87
TEM Tempus Ai Inc	61.96	8.97B	640.44M	-743.28M	-206.93M	-11.29
HQY Healthequity Inc	90.38	7.61B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	40.08	6.83B	906.14M	-52.62M	89.62M	-0.3621

Optimizerx Corp Stock (OPRX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-01-08	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2024-12-20	Eingeleitet	Stephens	Equal-Weight
2024-07-25	Fortgesetzt	B. Riley Securities	Buy
2024-04-04	Eingeleitet	JMP Securities	Mkt Outperform
2024-01-03	Eingeleitet	Barclays	Equal Weight
2023-02-02	Fortgesetzt	B. Riley Securities	Buy
2022-11-01	Eingeleitet	Stifel	Buy
2022-07-15	Eingeleitet	SVB Leerink	Outperform
2021-10-18	Fortgesetzt	B. Riley Securities	Buy
2021-04-13	Eingeleitet	RBC Capital Mkts	Outperform
2019-01-03	Eingeleitet	William Blair	Outperform

Alle ansehen

Optimizerx Corp Aktie (OPRX) Neueste Nachrichten

04:16 AM

JPMorgan Chase & Co. Purchases 52,169 Shares of OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat

04:16 AM

May 08, 2025

OptimizeRx Co. (NASDAQ:OPRX) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World

May 08, 2025

May 07, 2025

Connors Investor Services Inc. Has $287,000 Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat

May 02, 2025

May 01, 2025

OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report - The Manila Times

May 01, 2025

Healthcare Tech Leader OptimizeRx Jumps to Elite 1st Decile in ESG Rating: Key 2025 Report Findings - Stock Titan

May 01, 2025

Apr 30, 2025

Geode Capital Management LLC Has $1.95 Million Stock Holdings in OptimizeRx Co. (NASDAQ:OPRX) - Defense World

Apr 30, 2025

Apr 28, 2025

Walleye Capital LLC Acquires Shares of 138,575 OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat

Apr 28, 2025

Apr 24, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 24, 2025

Apr 23, 2025

OptimizeRx Corp. to Host Conference Call on Q1 2025 Financial Results on May 12, 2025 - Nasdaq

Apr 23, 2025

OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET - The Manila Times

Apr 23, 2025

Apr 19, 2025

Kennedy Capital Management LLC Increases Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat

Apr 19, 2025

Apr 18, 2025

Analysts Set OptimizeRx Co. (NASDAQ:OPRX) Target Price at $9.06 - MarketBeat

Apr 18, 2025

OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment - The Manila Times

Apr 18, 2025

Apr 16, 2025

Whetstone Capital Advisors LLC Invests $6.56 Million in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat

Apr 16, 2025

Apr 07, 2025

OptimizeRx Co. (NASDAQ:OPRX) Short Interest Up 22.0% in March - MarketBeat

Apr 07, 2025

Apr 06, 2025

Is OptimizeRx Corporation (NASDAQ:OPRX) Expensive For A Reason? A Look At Its Intrinsic Value - simplywall.st

Apr 06, 2025

Apr 05, 2025

Blair William & Co. IL Reduces Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat

Apr 05, 2025

Apr 04, 2025

OptimizeRx Co. (NASDAQ:OPRX) Sees Significant Increase in Short Interest - Defense World

Apr 04, 2025

Mar 30, 2025

OptimizeRx Corporation (NASDAQ:OPRX) is favoured by institutional owners who hold 59% of the company - Yahoo Finance

Mar 30, 2025

Mar 29, 2025

Bank of New York Mellon Corp Has $426,000 Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World

Mar 29, 2025

Mar 28, 2025

OptimizeRx Files $75 Million Mixed Shelf - Marketscreener.com

Mar 28, 2025

OptimizeRx Corp Files For Mixed Shelf Of Up To $75 MillionSEC Filing - MarketScreener

Mar 28, 2025

Mar 24, 2025

OptimizeRx Co. (NASDAQ:OPRX) Director James Paul Lang Purchases 321,408 Shares - MarketBeat

Mar 24, 2025

Royce & Associates LP Takes Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat

Mar 24, 2025

Mar 22, 2025

OptimizeRx Corp (NASDAQ: OPRX): The Metrics That Matter Right Now - Stocks Register

Mar 22, 2025

OptimizeRx Co. (NASDAQ:OPRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Mar 22, 2025

Mar 20, 2025

OptimizeRx Corp SEC 10-K Report - TradingView

Mar 20, 2025

OptimizeRx director James Lang purchases $2.44 million in common stock - Investing.com Australia

Mar 20, 2025

Mar 19, 2025

OptimizeRx director James Lang purchases $2.44 million in common stock By Investing.com - Investing.com South Africa

Mar 19, 2025

OptimizeRx (OPRX) to Release Quarterly Earnings on Wednesday - MarketBeat

Mar 19, 2025

Mar 18, 2025

Q1 Earnings Forecast for OptimizeRx Issued By B. Riley - MarketBeat

Mar 18, 2025

Head to Head Review: OptimizeRx (NASDAQ:OPRX) & CFN Enterprises (OTCMKTS:CNFN) - Defense World

Mar 18, 2025

Mar 17, 2025

Why OptimizeRx Corp. (OPRX) Soared Last Week? - Insider Monkey

Mar 17, 2025